Nearly one in three Americans over the age of 60 — roughly 19 million people — take aspirin daily, according to a 2021 study.

Adjuvant treatment with aspirin is associated with a lower risk of recurrence at 3 years in CRC patients with PI3K pathway ...

After guideline changes, aspirin use dropped off overall, even for higher-risk patients in whom it might still be considered.

Among older adults and adults with low atherosclerotic cardiovascular disease (ASCVD) risk for whom aspirin is not rec ...

Following landmark clinical trials and changes in guideline recommendations, self-reported primary prevention aspirin use decreased among older adults and adults with low ...

The prevalence of daily low-dose aspirin use fell significantly after the American College of Cardiology and the American ...

Aspirin did not provide any clinical benefits in a cohort of patients with colorectal cancer who had no history of cardiovascular disease or stroke.

The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.

For decades, aspirin has been the standard preventive treatment for patients with blood vessel disease. After an acute ...

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

Aspirin reduced disease recurrence in patients PI3K-mutated colorectal cancer, underscoring the value of early genomic ...